C. Vogelmeier (Marburg, Germany), O.C. Burghuber (Vienna, Austria)
Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: "REDUCE*", a non-inferiority multicenter trial. (*Reduction in the Use of Corticosteroids in Exacerbated COPD; ISRCTN19646069)
J.D. Leuppi, P. Schütz, R. Bingisser, M. Briel, T. Drescher, U. Dürring, C. Henzen, Y. Leibbrandt, S. Maier, D. Miedinger, B. Müller, A. Scherr, C. Schindler, R. Stöckli, S. Viatte, C. von Garnier, M. Tamm, J. Rutishauser (Basel, Aarau, Luzern, Biel-Bienne, Bern, Switzerland)
|  |
Relationship between exacerbation frequency and survival post MI in COPD patients
J. Quint, E. Herrett, A. Timmis, H. Hemingway, J. Wedzicha, L. Smeeth (London, United Kingdom)
| |
The impact of airway infection on cardiovascular risk during COPD exacerbations
A.R.C. Patel, G.C. Donaldson, B.S. Kowlessar, A.J. Mackay, D. Garcha, S. George, J.A. Wedzicha, J.R. Hurst (London, United Kingdom)
| |
Evaluation of multiple admissions of COPD patients: European COPD audit
J.L. Lopez-Campos, S. Hartl, F. Pozo-Rodriguez, M. Roberts (Seville, Madrid, Spain; Vienna, Austria; London, United Kingdom)
|  |
Emergency oxygen use and monitoring in the pre-hospital and acute hospital setting – The significance of a common problem
J. Johnstone, L. Malpas, F. Johnstone, M. Malpas (Worcester, Birmingham, United Kingdom)
|  |
An audit of inpatient mortality and readmission rates in acute exacerbation of COPD – Exploring the role of comorbidity and inflammatory markers
A. McClintock-Tiongco, A. Patel, I. Chakravorty (London, United Kingdom)
| |
Differences between men and women COPD admissions: Evidence from the European COPD audit
C.M. Roberts, S. Hartl, F. Pozo-Rodriguez, J.L. Lopez-Campos (London, United Kingdom; Vienna, Austria; Madrid, Seville, Spain)
| |
Acute exacerbation of COPD is associated with three-fold elevation of cardiac troponin T
V. Søyseth, R. Bhatnagar, N. Holmedahl, G. Einvik (Lørenskog, Hakadal, Norway)
| |